A1AG2_HUMAN - dbPTM
A1AG2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID A1AG2_HUMAN
UniProt AC P19652
Protein Name Alpha-1-acid glycoprotein 2
Gene Name ORM2
Organism Homo sapiens (Human).
Sequence Length 201
Subcellular Localization Secreted.
Protein Description Functions as transport protein in the blood stream. Binds various hydrophobic ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability. Appears to function in modulating the activity of the immune system during the acute-phase reaction..
Protein Sequence MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLCIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGES
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MALSWVLTVLS
----CHHHHHHHHHH
12.9524043423
8PhosphorylationMALSWVLTVLSLLPL
CHHHHHHHHHHHHHH
15.1324043423
11PhosphorylationSWVLTVLSLLPLLEA
HHHHHHHHHHHHHHC
24.4324043423
19Pyrrolidone_carboxylic_acidLLPLLEAQIPLCANL
HHHHHHCCCCCCCCC
28.5815253437
19Pyrrolidone_carboxylic_acidLLPLLEAQIPLCANL
HHHHHHCCCCCCCCC
28.5815253437
19Pyrrolidone_carboxylic_acidLLPLLEAQIPLCANL
HHHHHHCCCCCCCCC
28.58-
32PhosphorylationNLVPVPITNATLDRI
CCCEEECCCCCHHHH
16.8424043423
33N-linked_GlycosylationLVPVPITNATLDRIT
CCEEECCCCCHHHHC
31.4822171320
33N-linked_GlycosylationLVPVPITNATLDRIT
CCEEECCCCCHHHHC
31.4822171320
35PhosphorylationPVPITNATLDRITGK
EEECCCCCHHHHCCC
31.1224043423
40PhosphorylationNATLDRITGKWFYIA
CCCHHHHCCCEEEHH
33.3324043423
45NitrationRITGKWFYIASAFRN
HHCCCEEEHHHHHCC
8.41-
55NitrationSAFRNEEYNKSVQEI
HHHCCHHHHHHHHHC
23.01-
56N-linked_GlycosylationAFRNEEYNKSVQEIQ
HHCCHHHHHHHHHCC
33.151567356
56N-linked_GlycosylationAFRNEEYNKSVQEIQ
HHCCHHHHHHHHHCC
33.154711474
65PhosphorylationSVQEIQATFFYFTPN
HHHHCCEEEEEECCC
9.6325627689
68NitrationEIQATFFYFTPNKTE
HCCEEEEEECCCCCC
11.44-
72N-linked_GlycosylationTFFYFTPNKTEDTIF
EEEEECCCCCCCEEE
61.901567356
72N-linked_GlycosylationTFFYFTPNKTEDTIF
EEEEECCCCCCCEEE
61.9018638581
93N-linked_GlycosylationRQNQCFYNSSYLNVQ
CCCCCCCCCCCEEEE
12.2918638581
93N-linked_GlycosylationRQNQCFYNSSYLNVQ
CCCCCCCCCCCEEEE
12.291567356
96NitrationQCFYNSSYLNVQREN
CCCCCCCCEEEEEEC
11.34-
98N-linked_GlycosylationFYNSSYLNVQRENGT
CCCCCCEEEEEECCC
21.4617623646
98N-linked_GlycosylationFYNSSYLNVQRENGT
CCCCCCEEEEEECCC
21.4617623646
103N-linked_GlycosylationYLNVQRENGTVSRYE
CEEEEEECCCEEEEC
54.334711474
103N-linked_GlycosylationYLNVQRENGTVSRYE
CEEEEEECCCEEEEC
54.331567356
109NitrationENGTVSRYEGGREHV
ECCCEEEECCCHHEE
16.06-
132PhosphorylationTKTLMFGSYLDDEKN
CCEEEECCEECCCCC
15.9724043423
133NitrationKTLMFGSYLDDEKNW
CEEEECCEECCCCCC
17.96-
133PhosphorylationKTLMFGSYLDDEKNW
CEEEECCEECCCCCC
17.9624043423
145NitrationKNWGLSFYADKPETT
CCCCCEEECCCCCCC
15.54-
160NitrationKEQLGEFYEALDCLC
HHHHHHHHHHHHHEE
8.94-
175NitrationIPRSDVMYTDWKKDK
EEHHHCCCCCCCCCC
11.03-
179AcetylationDVMYTDWKKDKCEPL
HCCCCCCCCCCCHHH
54.6330586329
188GlycationDKCEPLEKQHEKERK
CCCHHHHHHHHHHHH
65.72-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of A1AG2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of A1AG2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of A1AG2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
STK3_HUMANSTK3physical
21988832
PRDX6_HUMANPRDX6physical
21988832

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of A1AG2_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD.";
Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
Mol. Cell. Proteomics 0:0-0(2011).
Cited for: GLYCOSYLATION AT ASN-33, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY.
"Enrichment of glycopeptides for glycan structure and attachment siteidentification.";
Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.;
Nat. Methods 6:809-811(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33, STRUCTURE OFCARBOHYDRATES, AND MASS SPECTROMETRY.
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-93 ANDASN-103, AND MASS SPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72; ASN-93AND ASN-103, AND MASS SPECTROMETRY.
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry.";
Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
Proteomics 4:454-465(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-56; ASN-72 ANDASN-93, AND MASS SPECTROMETRY.
"A proteomic analysis of human bile.";
Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
Mol. Cell. Proteomics 3:715-728(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33, AND MASS SPECTROMETRY.
"A new strategy for identification of N-glycosylated proteins andunambiguous assignment of their glycosylation sites using HILICenrichment and partial deglycosylation.";
Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P.;
J. Proteome Res. 3:556-566(2004).
Cited for: PYROGLUTAMATE FORMATION AT GLN-19, GLYCOSYLATION AT ASN-33 AND ASN-93,AND MASS SPECTROMETRY.
"Analysis of the five glycosylation sites of human alpha 1-acidglycoprotein.";
Treuheit M.J., Costello C.E., Halsall H.B.;
Biochem. J. 283:105-112(1992).
Cited for: GLYCOSYLATION AT ASN-33; ASN-56; ASN-72; ASN-93 AND ASN-103.

TOP